1
|
Bhattacharjee D, Vracar S, Round RA, Nightingale PG, Williams JA, Gkoutos GV, Stratton IM, Parker R, Luzio SD, Webber J, Manley SE, Roberts GA, Ghosh S. Utility of HbA 1c assessment in people with diabetes awaiting liver transplantation. Diabet Med 2019; 36:1444-1452. [PMID: 30474191 PMCID: PMC6850030 DOI: 10.1111/dme.13870] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/22/2018] [Indexed: 02/06/2023]
Abstract
AIMS To investigate the relationship between HbA1c and glucose in people with co-existing liver disease and diabetes awaiting transplant, and in those with diabetes but no liver disease. METHODS HbA1c and random plasma glucose data were collected for 125 people with diabetes without liver disease and for 29 people awaiting liver transplant with diabetes and cirrhosis. Cirrhosis was caused by non-alcoholic fatty liver disease, hepatitis C, alcoholic liver disease, hereditary haemochromatosis, polycystic liver/kidneys, cryptogenic/non-cirrhotic portal hypertension and α-1-antitrypsin-related disease. RESULTS The median (interquartile range) age of the diabetes with cirrhosis group was 55 (49-63) years compared to 60 (50-71) years (P=0.13) in the group without cirrhosis. In the diabetes with cirrhosis group there were 21 men (72%) compared with 86 men (69%) in the group with diabetes and no cirrhosis (P=0.82). Of the group with diabetes and cirrhosis, 27 people (93%) were of white European ethnicity, two (7%) were South Asian and none was of Afro-Caribbean/other ethnicity compared with 94 (75%), 16 (13%), 10 (8%)/5 (4%), respectively, in the group with diabetes and no cirrhosis (P=0.20). Median (interquartile range) HbA1c was 41 (32-56) mmol/mol [5.9 (5.1-7.3)%] vs 61 (52-70) mmol/mol [7.7 (6.9-8.6)%] (P<0.001), respectively, in the diabetes with cirrhosis group vs the diabetes without cirrhosis group. The glucose concentrations were 8.4 (7.0-11.2) mmol/l vs 7.3 (5.2-11.5) mmol/l (P=0.17). HbA1c was depressed by 20 mmol/mol (1.8%; P<0.001) in 28 participants with cirrhosis but elevated by 28 mmol/mol (2.6%) in the participant with α-1-antitrypsin disorder. Those with cirrhosis and depressed HbA1c had fewer larger erythrocytes, and higher red cell distribution width and reticulocyte count. This was reflected in the positive association of glucose with mean cell volume (r=0.39) and haemoglobin level (r=0.49) and the negative association for HbA1c (r=-0.28 and r=-0.26, respectively) in the diabetes group with cirrhosis. CONCLUSION HbA1c is not an appropriate test for blood glucose in people with cirrhosis and diabetes awaiting transplant as it reflects altered erythrocyte presentation.
Collapse
Affiliation(s)
| | - S. Vracar
- Medical SchoolUniversity of BirminghamBirminghamUK
| | - R. A. Round
- Clinical Laboratory ServicesUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
- Diabetes Translational Research GroupDiabetes CentreQueen Elizabeth Hospital BirminghamUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
- Institute of Translational MedicineUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
| | - P. G. Nightingale
- Institute of Translational MedicineUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
| | - J. A. Williams
- Institute of Translational MedicineUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
- College of Medical and Dental SciencesInstitute of Cancer and Genomic SciencesUniversity of BirminghamBirminghamUK
- Mammalian Genetics UnitMedical Research Council Harwell InstituteHarwellUK
| | - G. V. Gkoutos
- Institute of Translational MedicineUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
- College of Medical and Dental SciencesInstitute of Cancer and Genomic SciencesUniversity of BirminghamBirminghamUK
- MRC Health Data Research UK (HDR UK)BirminghamUK
- NIHR Experimental Cancer Medicine CentreBirminghamUK
- NIHR Surgical Reconstruction and Microbiology Research CentreBirminghamUK
- NIHR Biomedical Research CentreBirminghamUK
| | - I. M. Stratton
- Gloucestershire Retinal Research GroupGloucestershire Hospitals NHS Foundation TrustCheltenhamUK
| | - R. Parker
- Leeds Liver UnitSt James's University HospitalLeedsUK
| | - S. D. Luzio
- Diabetes Translational Research GroupDiabetes CentreQueen Elizabeth Hospital BirminghamUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
- Diabetes Research GroupSwansea UniversitySwansea
| | - J. Webber
- Diabetes Translational Research GroupDiabetes CentreQueen Elizabeth Hospital BirminghamUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
| | - S. E. Manley
- Diabetes Translational Research GroupDiabetes CentreQueen Elizabeth Hospital BirminghamUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
- Institute of Translational MedicineUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
- College of Medical and Dental SciencesInstitute of Metabolism and Systems ResearchUniversity of BirminghamBirmingham
| | - G. A. Roberts
- Diabetes Translational Research GroupDiabetes CentreQueen Elizabeth Hospital BirminghamUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
- Diabetes Research GroupSwansea UniversitySwansea
- HRB‐Clinical Research Facility ‐ CorkUniversity College CorkCorkIreland
| | - S. Ghosh
- Diabetes Translational Research GroupDiabetes CentreQueen Elizabeth Hospital BirminghamUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
- Institute of Translational MedicineUniversity Hospitals Birmingham NHS Foundation TrustBirminghamUK
| |
Collapse
|
2
|
Affiliation(s)
- J. A. Williams
- Department of Anthropology University of North Dakota Grand Forks, North Dakota 58202
| | | |
Collapse
|
3
|
Williams JA, Baxter W, Collins G, Harding K, Leslie CM, Sills RJ. The Application of High Gradient Magnetic Separation in Nuclear Fuel Reprocessing. NUCL TECHNOL 2017. [DOI: 10.13182/nt81-a32671] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- J. A. Williams
- British Nuclear Fuels Limited Risley, Warrington WA3 6AS, Cheshire, United Kingdom
| | - W. Baxter
- British Nuclear Fuels Limited Windscale Works, Seascale, Cumbria CA20 IPG, United Kingdom
| | - G. Collins
- United Kingdom Atomic, Energy Authority Dounreay Nuclear Power Development Establishment Thurso, Caithness KW14 7TL, United Kingdom
| | - K. Harding
- United Kingdom Atomic, Energy Authority Atomic Energy Establishment, Winfrith, Dorchester, Dorset DT2 8DH, United Kingdom
| | - C. M. Leslie
- British Nuclear Fuels Limited Windscale Works, Seascale, Cumbria CA20 IPG, United Kingdom
| | - R. J. Sills
- British Nuclear Fuels Limited Windscale Works, Seascale, Cumbria CA20 IPG, United Kingdom
| |
Collapse
|
4
|
Spicer LJ, Schütz LF, Williams JA, Schreiber NB, Evans JR, Totty ML, Gilliam JN. G protein-coupled receptor 34 in ovarian granulosa cells of cattle: changes during follicular development and potential functional implications. Domest Anim Endocrinol 2017; 59:90-99. [PMID: 28040605 PMCID: PMC5357439 DOI: 10.1016/j.domaniend.2016.12.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/19/2016] [Revised: 11/30/2016] [Accepted: 12/01/2016] [Indexed: 01/08/2023]
Abstract
Abundance of G protein-coupled receptor 34 (GPR34) mRNA is greater in granulosa cells (GCs) of cystic vs normal follicles of cattle. The present experiments were designed to determine if GPR34 mRNA in granulosa cell [GC] changes during selection and growth of dominant follicles in cattle as well as to investigate the hormonal regulation of GPR34 mRNA in bovine GC in vitro. In Exp. 1, estrous cycles of nonlactating cows were synchronized and then ovariectomized on either day 3-4 or 5-6 after ovulation. GPR34 mRNA abundance in GC was 2.8- to 3.8-fold greater (P < 0.05) in small (1-5 mm) and large (≥8 mm) estrogen-inactive dominant follicles than in large estrogen-active follicles. Also, GPR34 mRNA tended to be greater (P < 0.10) in F2 than F1 follicles on day 3-4 postovulation. In Exp. 2-7, ovaries were collected at an abattoir and GC were isolated and treated in vitro. Expression of GPR34 was increased (P < 0.05) 2.2-fold by IGF1. Tumor necrosis factor (TNF)-α decreased (P < 0.05) the IGF1-induced GPR34 mRNA abundance in small-follicle GC, whereas IGF1 decreased (P < 0.05) GPR34 expression by 45% in large-follicle GC. Treatment of small-follicle GC with either IL-2, prostaglandin E2 or angiogenin decreased (P < 0.05) GPR34 expression, whereas FSH, cortisol, wingless 3A, or hedgehog proteins did not affect (P > 0.10) GPR34 expression. In Exp. 6 and 7, 2 presumed ligands of GPR34, L-a-lysophosphatidylserine (LPPS) and LPP-ethanolamine, increased (P < 0.05) GC numbers and estradiol production by 2-fold or more in small-follicle GC, and this response was only observed in IGF1-treated GC. In conclusion, GPR34 is a developmentally and hormonally regulated gene in GC, and its presumed ligands enhance IGF1-induced proliferation and steroidogenesis of bovine GC.
Collapse
Affiliation(s)
- L J Spicer
- Department of Animal Science, Oklahoma State University, Stillwater, OK 74078, USA.
| | - L F Schütz
- Department of Animal Science, Oklahoma State University, Stillwater, OK 74078, USA
| | - J A Williams
- Department of Animal Science, Oklahoma State University, Stillwater, OK 74078, USA
| | - N B Schreiber
- Department of Animal Science, Oklahoma State University, Stillwater, OK 74078, USA
| | - J R Evans
- Department of Animal Science, Oklahoma State University, Stillwater, OK 74078, USA
| | - M L Totty
- Department of Animal Science, Oklahoma State University, Stillwater, OK 74078, USA
| | - J N Gilliam
- Department of Veterinary Clinical Sciences, Oklahoma State University, Stillwater, OK 74078, USA
| |
Collapse
|
5
|
Scheerens H, Malong A, Bassett K, Boyd Z, Gupta V, Harris J, Mesick C, Simnett S, Stevens H, Gilbert H, Risser P, Kalamegham R, Jordan J, Engel J, Chen S, Essioux L, Williams JA. Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch. Clin Transl Sci 2017; 10:84-92. [PMID: 28121072 PMCID: PMC5355969 DOI: 10.1111/cts.12455] [Citation(s) in RCA: 79] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2016] [Accepted: 01/18/2017] [Indexed: 02/06/2023] Open
Abstract
US Food and Drug Administration (FDA)‐approved diagnostic assays play an increasingly common role in managing patients to prolong lifespan while also enhancing quality of life. Diagnostic assays can be essential for the safe and effective use of therapeutics (companion diagnostic), or may inform on improving the benefit/risk ratio without restricting drug access (complementary diagnostic). This tutorial reviews strategic considerations for drug and assay development resulting in FDA‐approved companion or complementary diagnostic status.
Collapse
Affiliation(s)
- H Scheerens
- Genentech Inc., San Francisco, California, USA
| | - A Malong
- Genentech Inc., San Francisco, California, USA
| | - K Bassett
- Genentech Inc., San Francisco, California, USA
| | - Z Boyd
- Genentech Inc., San Francisco, California, USA
| | - V Gupta
- Genentech Inc., San Francisco, California, USA
| | - J Harris
- Genentech Inc., San Francisco, California, USA
| | - C Mesick
- Genentech Inc., San Francisco, California, USA
| | - S Simnett
- Genentech Inc., San Francisco, California, USA
| | | | - H Gilbert
- Genentech Inc., San Francisco, California, USA
| | - P Risser
- Genentech Inc., San Francisco, California, USA
| | | | | | - J Engel
- Roche AG, Basel, Switzerland
| | - S Chen
- Roche AG, Basel, Switzerland
| | - L Essioux
- Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche, Ltd, Basel, Switzerland
| | | |
Collapse
|
6
|
|
7
|
Simonelli M, Zucali P, Santoro A, Thomas MB, de Braud FG, Borghaei H, Berlin J, Denlinger CS, Noberasco C, Rimassa L, Kim TY, English PA, Abbattista A, Gallo Stampino C, Carpentieri M, Williams JA. Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma. Ann Oncol 2016; 27:1782-7. [PMID: 27329247 DOI: 10.1093/annonc/mdw240] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2016] [Accepted: 06/09/2016] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND This expansion cohort of a multicenter, dose-escalation, phase I study (NCT00557856) evaluated safety, tolerability, antitumor activity, pharmacokinetics, and pharmacodynamic effects of the anti-activin receptor-like kinase-1 (ALK-1) monoclonal antibody PF-03446962 in advanced hepatocellular carcinoma (HCC). PATIENTS AND METHODS Patients with HCC and disease progression after prior antiangiogenic therapy or intolerance to treatment received PF-03446962 7 mg/kg intravenously biweekly, as recommended in the dose-escalation part of the study. RESULTS Twenty-four patients received PF-03446962. The most frequent treatment-related adverse events (AEs) were thrombocytopenia (33.3%), asthenia (29.2), and chills (16.7%). Two patients experienced treatment-related telangiectasia, suggesting an in vivo knockout of ALK-1 function through ALK-1 pathway inhibition. Overall, treatment-related grade 3-4 AEs were reported in eight patients (33.3%). Treatment-related grade 3-4 thrombocytopenia was noted in four patients. No complete or partial responses were reported. Twelve (50%) patients achieved stable disease, which lasted ≥12 weeks in seven (29.2%) patients. The median time to progression was 3 months. Biomarker analyses showed higher mean tumor expression of c-tumor mesenchymal-epithelial transition factor and higher mean serum levels of bone morphogenetic protein-9 in patients with disease control (DC) for ≥12 weeks versus patients with disease progression. Conversely, lower mean serum transforming growth factor-β and vascular endothelial growth factor receptor-3 levels were detected in patients with DC versus patients with progression. CONCLUSIONS The observed safety, tolerability, pharmacokinetic profile, and clinical activity support further evaluation of PF-03446962 in patients with HCC and other solid malignancies, as single agent or in combination with other antiangiogenic, chemotherapeutic, or immunotherapeutic agents. TRIAL REGISTRATION NUMBER NCT00557856.
Collapse
Affiliation(s)
- M Simonelli
- Humanitas Clinical and Research Center, Humanitas Cancer Center, Rozzano, Milano, Italy
| | - P Zucali
- Humanitas Clinical and Research Center, Humanitas Cancer Center, Rozzano, Milano, Italy
| | - A Santoro
- Humanitas Clinical and Research Center, Humanitas Cancer Center, Rozzano, Milano, Italy
| | - M B Thomas
- Division of Hematology/Oncology, Medical University of South Carolina, Charleston, USA
| | - F G de Braud
- Department of Medical Oncology, European Institute of Oncology, Milan, Italy
| | - H Borghaei
- Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia
| | - J Berlin
- Department of Gastrointestinal Oncology, Vanderbilt University, Nashville, USA
| | - C S Denlinger
- Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia
| | - C Noberasco
- Department of Medical Oncology, European Institute of Oncology, Milan, Italy
| | - L Rimassa
- Humanitas Clinical and Research Center, Humanitas Cancer Center, Rozzano, Milano, Italy
| | - T-Y Kim
- Department of Medical Oncology/Hematology, Seoul National Hospital, Seoul, Republic of Korea
| | | | | | | | | | | |
Collapse
|
8
|
Kang YK, Yau T, Park JW, Lim HY, Lee TY, Obi S, Chan SL, Qin S, Kim RD, Casey M, Chen C, Bhattacharyya H, Williams JA, Valota O, Chakrabarti D, Kudo M. Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma. Ann Oncol 2015; 26:2457-63. [PMID: 26386123 DOI: 10.1093/annonc/mdv388] [Citation(s) in RCA: 70] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2015] [Accepted: 09/10/2015] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND The efficacy and safety of axitinib, a potent and selective vascular endothelial growth factor receptors 1-3 inhibitor, combined with best supportive care (BSC) was evaluated in a global, randomized, placebo-controlled phase II trial in patients with locally advanced or metastatic hepatocellular carcinoma (HCC). PATIENTS AND METHODS Patients with HCC and Child-Pugh Class A who progressed on or were intolerant to one prior antiangiogenic therapy were stratified by tumour invasion (presence/absence of extrahepatic spread and/or vascular invasion) and region (Asian/non-Asian) and randomized (2:1) to axitinib/BSC (starting dose 5 mg twice-daily) or placebo/BSC. The primary end point was overall survival (OS). RESULTS The estimated hazard ratio for OS was 0.907 [95% confidence interval (CI) 0.646-1.274; one-sided stratified P = 0.287] for axitinib/BSC (n = 134) versus placebo/BSC (n = 68), with the median (95% CI) of 12.7 (10.2-14.9) versus 9.7 (5.9-11.8) months, respectively. Results of prespecified subgroup analyses in Asian versus non-Asian patients or presence versus absence of tumour invasion were consistent with the overall population. Improvements favouring axitinib/BSC (P < 0.01) were observed in secondary efficacy end point analyses [progression-free survival (PFS), time to tumour progression (TTP), and clinical benefit rate (CBR)], and were retained among Asian patients in the prespecified subgroup analyses. Overall response rate did not differ significantly between treatments and patient-reported outcomes favoured placebo/BSC. Most common all-causality adverse events with axitinib/BSC were diarrhoea (54%), hypertension (54%), and decreased appetite (47%). Baseline serum analyses identified potential new prognostic (interleukin-6, E-selectin, interleukin-8, angiopoietin-2, migration inhibitory factor, and c-MET) or predictive (E-selectin and stromal-derived factor-1) factors for survival. CONCLUSIONS Axitinib/BSC did not improve OS over placebo/BSC in the overall population or in stratification subgroups. However, axitinib/BSC resulted in significantly longer PFS and TTP and higher CBR, with acceptable toxicity in patients with advanced HCC. TRIAL REGISTRATION ClinicalTrials.gov, NCT01210495.
Collapse
Affiliation(s)
- Y-K Kang
- Department of Oncology, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea
| | - T Yau
- Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
| | - J-W Park
- National Cancer Center/Center for Liver Cancer, Goyang-si
| | - H Y Lim
- Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea
| | - T-Y Lee
- Division of Gastroenterology and Hepatology, Taichung Veterans General Hospital, Taichung, Taiwan
| | - S Obi
- Department of Hepatology, Sasaki Foundation Kyoundo Hospital, Tokyo, Japan
| | - S L Chan
- State Key Laboratory in Oncology of South China, Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong
| | - Sk Qin
- Nanjing Bayi Hospital, Nanjing, China
| | - R D Kim
- H. Lee Moffitt Cancer Center, Tampa
| | | | | | | | | | | | | | - M Kudo
- Department of Gastroenterology and Hepatology, Kinki University Hospital, Osaka, Japan
| |
Collapse
|
9
|
Twelves C, Chmielowska E, Havel L, Popat S, Swieboda-Sadlej A, Sawrycki P, Bycott P, Ingrosso A, Kim S, Williams JA, Chen C, Olszanski AJ, de Besi P, Schiller JH. Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer. Ann Oncol 2014; 25:132-8. [PMID: 24356624 DOI: 10.1093/annonc/mdt489] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
BACKGROUND Efficacy and safety of first-line axitinib/paclitaxel/carboplatin versus bevacizumab/paclitaxel/carboplatin in advanced non-squamous non-small-cell lung cancer (NSCLC) was evaluated. PATIENTS AND METHODS Patients with stage IIIB/IV disease stratified by adjuvant therapy and gender were randomised 1 : 1 to axitinib (5 mg twice daily) or bevacizumab [15 mg/kg every 3 weeks (Q3W)], both with paclitaxel (200 mg/m(2) Q3W)/carboplatin (AUC 6 mg min/ml Q3W). RESULTS The trial was discontinued after preliminary analysis. Median progression-free survival (primary end point) for axitinib (N = 58) and bevacizumab (N = 60), respectively, was 5.7 and 6.1 months [hazard ratio (HR) 1.09, 95% confidence interval (CI) 0.68-1.76; one-sided stratified P = 0.64]; median overall survival was 10.6 and 13.3 months (HR 1.12, 95% CI 0.74-1.69; one-sided stratified P = 0.70). Objective response rates (95% CI) were 29.3% (18.1-42.7) and 43.3% (30.6-56.8), respectively; risk ratio 0.676 (95% CI 0.41-1.11; one-sided stratified P = 0.94). The most common grade 3/4 adverse events included neutropenia (28% versus 20%), fatigue (14% versus 7%), and hypertension (14% versus 5%). Patient-reported outcomes based on the EORTC QLQ-C30 were similar between arms. CONCLUSIONS In patients with advanced non-squamous NSCLC, axitinib/paclitaxel/carboplatin did not improve efficacy versus bevacizumab/paclitaxel/carboplatin, and was less well tolerated.
Collapse
Affiliation(s)
- C Twelves
- Cancer Research UK Clinical Centre, St James's University Hospital, Leeds, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Evans JR, Schreiber NB, Williams JA, Spicer LJ. Effects of fibroblast growth factor 9 on steroidogenesis and control of FGFR2IIIc mRNA in porcine granulosa cells. J Anim Sci 2014; 92:511-9. [PMID: 24664559 PMCID: PMC10837796 DOI: 10.2527/jas.2013-6989] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023] Open
Abstract
The objectives of this study were to investigate the effects of fibroblast growth factor 9 (FGF9) on hormone-stimulated porcine granulosa cell proliferation and steroid production and to further elucidate the hormonal and developmental control of FGFR2IIIc gene expression in granulosa cells. Porcine ovaries were collected from a local slaughterhouse and granulosa cells were collected from small to medium (1 to 5 mm) follicles for 5 in vitro studies that were conducted. Cells were cultured for 48 h in 5% fetal calf serum plus 5% porcine serum and then treated with various combinations of FSH, IGF-I, FGF9, Sonic hedgehog (SHH), cortisol, PGE2, and/or wingless-type mouse mammary tumor virus integration site family member 5A (WNT5A) in serum-free medium for an additional 24 or 48 h. Medium was collected for analysis of steroid concentration via RIA, or RNA was collected for gene expression analysis of FGFR2IIIc via quantitative reverse transcription PCR. Fibroblast growth factor 9 stimulated (P < 0.05) IGF-I-induced estradiol production in the presence of FSH and testosterone. However, FGF9 had inconsistent effects on progesterone production, stimulating progesterone production in the presence of FSH and testosterone but inhibiting progesterone production in the presence of IGF-I, FSH, and testosterone. Cell numbers were increased (P < 0.05) by FGF9 in the presence of IGF-I and FSH but not in the presence of FSH and absence of IGF-I. For FGFR2IIIc mRNA studies, granulosa cells were treated with FSH, IGF-I, FGF9, SHH, cortisol, PGE2, or WNT5A. Follicle-stimulating hormone alone had no effect (P > 0.10) whereas IGF-I increased (P < 0.05) FGFR2IIIc mRNA abundance. Cortisol, PGE2, SHH, and WNT5A had no effect (P > 0.10) on FGFR2IIIc gene expression whereas FGF9 in the presence of FSH and IGF-I inhibited (P < 0.05) FGFR2IIIc gene expression. In an in vivo study, granulosa cells from large (7 to 14 mm) follicles had greater (P < 0.05) abundance of FGFR2IIIc mRNA than small (1 to 3 mm) or medium (4 to 6 mm) follicles. In conclusion, IGF-I-induced FGFR2IIIc mRNA may be a mechanism for increased responses to FGF9 in FSH plus IGF-I-treated granulosa cells. Fibroblast growth factor 9 and IGF-I may work together as amplifiers of follicular growth and granulosa cell differentiation by stimulating estradiol production and concomitantly stimulating granulosa cell growth in pigs.
Collapse
Affiliation(s)
- J R Evans
- Department of Animal Science, Oklahoma State University, Stillwater 74078
| | | | | | | |
Collapse
|
11
|
Groen HJM, Socinski MA, Grossi F, Juhasz E, Gridelli C, Baas P, Butts CA, Chmielowska E, Usari T, Selaru P, Harmon C, Williams JA, Gao F, Tye L, Chao RC, Blumenschein GR. A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC). Ann Oncol 2013; 24:2382-9. [PMID: 23788751 PMCID: PMC6267942 DOI: 10.1093/annonc/mdt212] [Citation(s) in RCA: 45] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2013] [Revised: 04/29/2013] [Accepted: 04/29/2013] [Indexed: 12/27/2022] Open
Abstract
BACKGROUND Combined inhibition of vascular, platelet-derived, and epidermal growth factor receptor (EGFR) pathways may overcome refractoriness to single agents in platinum-pretreated non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS This randomized, double-blind, multicenter, phase II trial evaluated sunitinib 37.5 mg/day plus erlotinib 150 mg/day versus placebo plus erlotinib continuously in 4-week cycles. Eligible patients had histologically confirmed stage IIIB or IV NSCLC previously treated with one or two chemotherapy regimens, including one platinum-based regimen. The primary end point was progression-free survival (PFS) by an independent central review. RESULTS One hundred and thirty-two patients were randomly assigned, and the median duration of follow-up was 17.7 months. The median PFS was 2.8 versus 2.0 months for the combination versus erlotinib alone (HR 0.898, P = 0.321). The median overall survival (OS) was 8.2 versus 7.6 months (HR 1.066, P = 0.617). Objective response rates (ORRs) were 4.6% and 3.0%, respectively. Sunitinib plus erlotinib was fairly well tolerated although most treatment-related adverse events (AEs) were more frequent than with erlotinib alone: diarrhea (55% versus 33%), rash (41% versus 30%), fatigue (31% versus 25%), decreased appetite (30% versus 13%), nausea (28% versus 14%), and thrombocytopenia (13% versus 0%). CONCLUSIONS The addition of sunitinib to erlotinib did not significantly improve PFS in patients with advanced, platinum-pretreated NSCLC.
Collapse
Affiliation(s)
- H J M Groen
- Department of Pulmonary Diseases, University Medical Center Groningen, Groningen, The Netherlands.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
|
13
|
Chittamma A, Marin SJ, Williams JA, Clark C, McMillin GA. Detection of In Utero Marijuana Exposure by GC-MS, Ultra-Sensitive ELISA and LC-TOF-MS Using Umbilical Cord Tissue. J Anal Toxicol 2013; 37:391-4. [DOI: 10.1093/jat/bkt052] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
14
|
Pol BVD, Williams JA, Pantone A, Arno J. P5.065 Evaluation of Three Different Diagnostic Systems For the Detection of Chlamydia Trachomatisand Neisseria Gonorrhoeaefrom Oral Specimens. Br J Vener Dis 2013. [DOI: 10.1136/sextrans-2013-051184.1109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
15
|
Pol BVD, Williams JA, Eddleman L, Fuller D, Taylor S, Schwebke J, Lebed J, Smith B, Nye M, Gaydos C. P5.093 Evaluation of a New Amplified DNA Assay on the Becton Dickinson Viper System in Extracted Mode For the Detection of Trichomonas Vaginalisfrom Vaginal Specimens. Br J Vener Dis 2013. [DOI: 10.1136/sextrans-2013-051184.1137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
16
|
Williams JA, Weaver B, Pol BVD, Mi D, Fortenberry JD. P3.061 Mycoplasma GenitaliumDNA Detected from Adolescent Males in a Longitudinal Cohort. Br J Vener Dis 2013. [DOI: 10.1136/sextrans-2013-051184.0521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
17
|
Williams JA, Eddleman L, LeMonte A, Pol BVD. P5.092 Evaluation of a Laboratory Developed Test For the Detection of Trichomonas VaginalisUsing a Modification of the Abbott M2000 Realtime System. Br J Vener Dis 2013. [DOI: 10.1136/sextrans-2013-051184.1136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
18
|
Pol BVD, Davis A, Smith AD, Williams JA, Zimet G. P3.074 Men’s Preferences For STD Screening Programs: Initial Prevalence of STD in the Study Population. Br J Vener Dis 2013. [DOI: 10.1136/sextrans-2013-051184.0534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
19
|
Berger MB, Xu X, Williams JA, Van de Ven CJM, Mozurkewich EL. Early hospital discharge of infants born to group B streptococci-positive mothers: a decision analysis. BJOG 2012; 119:439-48. [PMID: 22251453 DOI: 10.1111/j.1471-0528.2011.03249.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
OBJECTIVE To compare the cost-effectiveness of an additional 24-hour inpatient observation for asymptomatic term neonates born to group B streptococcus (GBS)-colonised mothers with adequate intrapartum antibiotic prophylaxis (IAP) after an initial 24-hour in-hospital observation. DESIGN Cost-effectiveness analysis from a societal perspective. SETTING United States. POPULATION Asymptomatic term neonates born to GBS-colonised mothers with IAP after an initial 24-hour in-hospital observation. METHODS Monte Carlo simulation for a decision tree model incorporating the following chance events: development of GBS sepsis during the second 24 hours of life, development of GBS sepsis between 48 hours and 7 days of life, prompt versus delayed treatment for sepsis, neonatal mortality and long-term health sequelae. MAIN OUTCOME MEASURES Expected cost and quality-adjusted life years (QALYs), Incremental cost-effectiveness ratio (ICER). RESULTS Delayed, versus early, hospital discharge results in similar mean expected QALYs, but substantially higher expected cost. The mean difference in QALY is 0.00016 (95% CI 0.00005-0.00040), whereas the mean difference in cost is $1170.96 (95% CI $750.13-1584.32). The ICER is estimated to be $9,771,520.87 per QALY (95% CI $2,573,139.89-24,407,017.82). The proportion of early-onset GBS that develops during the second 24 hours of life, the cost of 24 hours of inpatient observation, and the probability of long-term sequelae following prompt versus delayed treatment play important roles in determining the cost-effectiveness of delayed hospital discharge. CONCLUSION Cost-effectiveness analysis suggests that with adequate IAP, discharging asymptomatic term neonates to home after 24 hours is the preferred approach compared with 48 hours inpatient observation.
Collapse
Affiliation(s)
- M B Berger
- Department of Obstetrics and Gynecology, University of Michigan Health System, L4000 Women’s Hospital, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5276, USA.
| | | | | | | | | |
Collapse
|
20
|
Agreda P, Dize L, West S, Williams JA, Van Der Pol B, Gaydos CA. P3-S1.16 Comparison of the Abbott m2000 RealTime CT assay for Chlamydia trachomatis monitoring in Tanzania compared to the Roche Amplicor CT assay. Br J Vener Dis 2011. [DOI: 10.1136/sextrans-2011-050108.416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
21
|
Williams JA, Brennan M, Chen Y, Tortorici MA, Pithavala YK, Liu YC. A meta-analysis of potential contribution of genetic polymorphisms in drug-metabolizing enzymes/transporters to axitinib pharmacokinetic (PK) variability in healthy volunteers. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e13033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
22
|
Harmon CS, Figlin RA, Hutson TE, Michaelson MD, Negrier S, Kim ST, Huang X, Williams JA, Motzer RJ. Circulating protein biomarkers of sunitinib (SU) and interferon-α (IFN-α) efficacy in treatment (Tx)-naive patients (pts) with metastatic renal cell carcinoma (mRCC). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.10525] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
23
|
Carrato A, Gao F, Richmond JL, Williams JA, Lin X, Jonker D, Sun Y, De la Cruz JA, Tursi JM, Lechuga MJ, Van Cutsem E. Abstract 289: Associations between germline genotype and efficacy and safety outcomes in a phase III study of sunitinib (SU) and FOLFIRI in metastatic colorectal cancer (mCRC). Cancer Res 2011. [DOI: 10.1158/1538-7445.am2011-289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: SU is an oral, multitargeted inhibitor of VEGFRs, PDGFRs, KIT, FLT3, CSF-1R and RET. In a phase III mCRC study, adding SU to FOLFIRI did not improve progression-free survival (PFS) vs. FOLFIRI/placebo. Potential correlations were investigated between germline genotype and safety/efficacy endpoints among patients (pts) in this trial.
Methods: Blood sample donation for genotype analysis was optional. Selection of genes and polymorphisms was based on prior reported associations. Twenty-one single-nucleotide polymorphisms (SNPs) in 10 genes (VEGF-A, VEGFR-2, CYP1A1, ABCG2, ABCB1, ABCC2, MTHFR, UGT1A1, FLT1 and FLT3) were analyzed by TaqMan allelic discrimination assay or fragment analysis, using DNA isolated from peripheral blood samples. All 21 polymorphisms were analyzed for associations with efficacy (PFS; overall survival [OS]) and selected safety endpoints. Results were adjusted for multiple testing of SNPs in linkage disequilibrium.
Results: Genotyping was performed in 139/768 pts (18%). Age and gender were similar between genotyped and non-genotyped pts, but the genotyped subset had fewer non-Caucasians (13% vs. 39%; Fisher's exact P<0.0001). Therefore, the statistical analysis reported here included Caucasians only. OS was superior in genotyped vs. non-genotyped pts (log rank P<0.0001). For the FOLFIRI/placebo arm only, the ABCC2 gene SNP rs717620 was associated with increased grade 3/4 diarrhea for those with the T allele (0/37 for C/C, 2/15 for C/T, 2/2 for T/T; Fisher's exact P=0.0003), and remained statistically significant after multiple testing adjustment. In the SU/FOLFIRI arm only, the common homozygous genotype A/A in the CYP1A1 gene at rs1048943 was associated with increased grade 3/4 neutropenia (39/59 for A/A, 1/6 for A/G, # of G/G = 0; Fisher's exact P=0.028), but lost significance after multiple testing adjustment. In the FOLFIRI/placebo arm only, a weak association was observed between poorer PFS and the common homozygous genotype T/T for the rs1045642 SNP (C3435T) in the ABCB1 gene (median [T/T] = 36 weeks [95% CI 24.9-40.6]; median [T/C] = 45 weeks [41.9-83.6]; median [C/C] = 55.1 weeks [31.8-55.1], HR [T/C vs. T/T] = 0.21 [95% CI 0.07-0.64]; HR [C/C vs. T/T] = 0.23 [95% CI 0.07-0.81]; log rank P=0.008; not significant after multiple testing adjustment).
Conclusions: Presence of the T allele in the ABCC2 gene at rs717620 was associated with increased risk of grade 3/4 diarrhea in a small number of Caucasian pts receiving FOLFIRI/placebo. No significant associations were identified between genotype and safety/efficacy endpoints in pts who received SU/FOLFIRI. As OS was superior in genotyped vs. non-genotyped pts, correlative findings may not be extrapolated beyond the genotyped subset. Further analysis of baseline characteristics is underway in the genotyped group to investigate this difference.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 289. doi:10.1158/1538-7445.AM2011-289
Collapse
Affiliation(s)
- A Carrato
- 1Ramon y Cajal University Hospital, Madrid, Spain
| | | | | | | | - X. Lin
- 4Pfizer Oncology, La Jolla, CA
| | - D. Jonker
- 5The Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada
| | - Y. Sun
- 6Cancer Institute and Chinese Academy Hospital of Medical Sciences, China, Panjia Yuan, Bejing, China
| | - J. A. De la Cruz
- 7Grupo Oncológico Acapulco Faculta de Medicina, UAG, Guerrero, Mexico
| | | | | | | | | |
Collapse
|
24
|
Baer RA, Williams JA, Osnes PG, Stokes TF. Delayed reinforcement as an indiscriminable contingency in verbal/nonverbal correspondence training. J Appl Behav Anal 2010; 17:429-40. [PMID: 16795679 PMCID: PMC1307965 DOI: 10.1901/jaba.1984.17-429] [Citation(s) in RCA: 59] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
We investigated the programming of generalization and maintenance of correspondence between verbal and nonverbal behavior in a preschool setting. Four children participated in a series of multiple-baseline designs. In Experiment 1, delayed reinforcement of verbal behavior effectively controlled maintenance of correspondence with previously trained responses and also resulted in generalization of correspondence to one untrained response. As the latter effect was limited, Experiment 2 was a further assessment of the effects of delayed reinforcement of generalization of correspondence to untrained responses, and consistent generalization was shown. Experiment 2 also showed that generalization, if lost, could be recovered through use of "booster training," in which the original contingencies were reinstated for a brief period. Experiment 3 provided replications, with two additional children, of the effects of delayed reinforcement on maintenance of correspondence. Results are discussed in terms of using delayed reinforcement as an indiscriminable contingency.
Collapse
|
25
|
Holloway RW, Roche M, DeMars L, Williams JA, Enke A, Klein A, Linke RG, Krasner CN. Immunotherapy with intraperitoneal catumaxomab in patients with advanced ovarian cancer after a complete response to chemotherapy: A phase II study. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.5015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
26
|
Miller MEY, Williams JA. Chronic renal failure in Jamaican children--an update (2001-2006). W INDIAN MED J 2009; 58:231-234. [PMID: 20043530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
OBJECTIVE This study evaluated the incidence, epidemiology, aetiology and outcome of chronic renal failure (CRF) in Jamaican children < 12 years old between 2001 and 2006. METHODS The required data on all children who fulfilled inclusion criteria were obtained from their medical records at the University Hospital of the West Indies, Bustamante Hospital for Children and from practitioners in hospitals serving children islandwide. RESULTS Eighteen new children (72.2% male) presented with CRF. The cumulative annual incidence was 4.61/million child population under age 12 years or 1.14/million total population. Congenital urological disease (44.5%) was the commonest cause of CRF, followed by glomerulonephritis (33.3%). Half of the cases of glomerulonephritis were secondary to HIV-associated nephropathy. Although all children with posterior urethral valves were diagnosed before age 6 months and promptly treated, renal failure present at birth proved irreversible. The mean age at diagnosis of CRF was 6.72 years. Ten children (55.6%) were already in CRF at first presentation with renal disease. Of these, the five with non-urological disease were already in End Stage Renal Disease (ESRD). Mortality was 44.4%. Five children died in ESRD without the benefit of dialysis. CONCLUSION The incidence of CRF has increased from the 1985-2000 local study and is mainly due to urological pathology which progresses despite early diagnosis and treatment. Non-urological renal disease is presenting too late for therapeutic intervention. Greater public awareness of symptoms of renal disease is needed. Children's access to dialysis is unpredictable. A paediatric dialysis and transplantation programme is needed.
Collapse
Affiliation(s)
- M E Y Miller
- Department of Child Health, The University of the West Indies, Kingston 7, Jamaica, West Indies.
| | | |
Collapse
|
27
|
|
28
|
Williams JA, Imamura M, Fregni F. Updates on the use of non-invasive brain stimulation in physical and rehabilitation medicine. J Rehabil Med 2009; 41:305-11. [DOI: 10.2340/16501977-0356] [Citation(s) in RCA: 91] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
29
|
Williams JA, Colton K, Fregni F, Pascual-Leone A, Alexander MP. Feasibility of a home constraint-induced movement therapy for hand weakness after stroke. J Rehabil Med 2009; 41:92-3. [DOI: 10.2340/16501977-0281] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
30
|
Sehgal A, Joiner W, Crocker A, Koh K, Sathyanarayanan S, Fang Y, Wu M, Williams JA, Zheng X. Molecular analysis of sleep: wake cycles in Drosophila. Cold Spring Harb Symp Quant Biol 2008; 72:557-64. [PMID: 18419315 DOI: 10.1101/sqb.2007.72.018] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Sleep is controlled by two major regulatory systems: a circadian system that drives it with a 24-hour periodicity and a home-ostatic system that ensures that adequate amounts of sleep are obtained. We are using the fruit fly Drosophila melanogaster to understand both types of regulation. With respect to circadian control, we have identified molecular mechanisms that are critical for the generation of a clock. Our recent efforts have focused on the analysis of posttranslational mechanisms, specifically the action of different phosphatases that control the phosphorylation and thereby the stability and/or nuclear localization of circadian clock proteins period (PER) and timeless (TIM). Resetting the clock in response to light is also mediated through posttranslational events that target TIM for degradation by the proteasome pathway; a recently identified ubiquitin ligase, jet lag (JET), is required for this response. Our understanding of the homeostatic control of sleep is in its early stages. We have found that mushroom bodies, which are a site of synaptic plasticity in the fly brain, are important for the regulation of sleep. In addition, through analysis of genes expressed under different behavioral states, we have identified some that are up-regulated during sleep deprivation. Thus, the Drosophila model allows the use of cellular and molecular approaches that should ultimately lead to a better understanding of sleep biology.
Collapse
Affiliation(s)
- A Sehgal
- Howard Hughes Medical Institute, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Cannata JM, Williams JA, Zhou QF, Sun L, Shung KK, Yu H, Kim ES. Self-focused ZnO transducers for ultrasonic biomicroscopy. J Appl Phys 2008; 103:84109-841094. [PMID: 19479005 PMCID: PMC2685215 DOI: 10.1063/1.2907716] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/07/2008] [Accepted: 02/14/2008] [Indexed: 05/18/2023]
Abstract
A simple fabrication technique was developed to produce high frequency (100 MHz) self-focused single element transducers with sputtered zinc oxide (ZnO) crystal films. This technique requires the sputtering of a ZnO film directly onto a curved backing substrate. Transducers were fabricated by sputtering an 18 mum thick ZnO layer on 2 mm diameter aluminum rods with ends shaped and polished to produce a 2 mm focus or f-number equal to one. The aluminum rod served a dual purpose as the backing layer and positive electrode for the resultant transducers. A 4 mum Parylene matching layer was deposited on the transducers after housing and interconnect. This matching layer was used to protect the substrate and condition the transfer of acoustic energy between the ZnO film and the load medium. The pulse-echo response for a representative transducer was centered at 101 MHz with a -6 dB bandwidth of 49%. The measured two way insertion loss was 44 dB. A tungsten wire phantom and an adult zebrafish eye were imaged to show the capability of these transducers.
Collapse
|
32
|
Myrand SP, Sekiguchi K, Man MZ, Lin X, Tzeng RY, Teng CH, Hee B, Garrett M, Kikkawa H, Lin CY, Eddy SM, Dostalik J, Mount J, Azuma J, Fujio Y, Jang IJ, Shin SG, Bleavins MR, Williams JA, Paulauskis JD, Wilner KD. Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations. Clin Pharmacol Ther 2008; 84:347-61. [PMID: 18231117 DOI: 10.1038/sj.clpt.6100482] [Citation(s) in RCA: 172] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Application of foreign clinical data across geographic regions can accelerate drug development. Drug disposition can be variable, and identification of factors influencing responsible pharmacokinetic/pharmacogenomic approaches could facilitate the universal application of foreign data and reduce the total amount of phase III clinical trials evaluating risks in different populations. Our objective was to establish and compare genotype (major cytochrome P450 (CYP) enzymes)/phenotype associations for Japanese (native and first- and third-generation Japanese living abroad), Caucasian, Chinese, and Korean populations using a standard drug panel. The mean metabolic ratios (MRs) for the four ethnic groups were similar except for a lower activity of CYP2D6 in Caucasians and CYP2C19 in Asians. Genotype, not ethnicity, impacted the MR for CYP2C9, CYP2C19, and CYP2D6; neither affected CYP1A2, CYP2E1, and CYP3A4/5 activities. We conclude that equivalent plasma drug concentrations and metabolic profiles can be expected for native Japanese, first- and third-generation Japanese, Koreans, and Chinese for compounds handled through these six CYP enzymes.
Collapse
Affiliation(s)
- S P Myrand
- Drug Safety Research & Development, Pfizer Global Research & Development (PGRD), Ann Arbor, Michigan, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Cannata JM, Williams JA, Zhou QF, Sun L, Shung KK, Yu H, Kim ES. Self-focused ZnO transducers for ultrasonic biomicroscopy. J Appl Phys 2008; 103:artno084109. [PMID: 18596925 PMCID: PMC2442463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
A simple fabrication technique was developed to produce high frequency (100 MHz) self-focused single element transducers with sputtered zinc oxide (ZnO) crystal films. This technique requires the sputtering of a ZnO film directly onto a curved backing substrate. Transducers were fabricated by sputtering an 18 μm thick ZnO layer on 2 mm diameter aluminum rods with ends shaped and polished to produce a 2 mm focus or f-number equal to one. The aluminum rod served a dual purpose as the backing layer and positive electrode for the resultant transducers. A 4 μm Parylene matching layer was deposited on the transducers after housing and interconnect. This matching layer was used to protect the substrate and condition the transfer of acoustic energy between the ZnO film and the load medium. The pulse-echo response for a representative transducer was centered at 101 MHz with a -6 dB bandwidth of 49%. The measured two way insertion loss was 44 dB. A tungsten wire phantom and an adult zebrafish eye were imaged to show the capability of these transducers.
Collapse
|
34
|
Abstract
This article reviews the origin and evolution of high throughput screening (HTS) through the experience of an individual pharmaceutical company, revealing some of the mysteries of the early stages of drug discovery to the wider pharmacology audience. HTS in this company (Pfizer, Groton, USA) had its origin in natural products screening in 1986, by substituting fermentation broths with dimethyl sulphoxide solutions of synthetic compounds, using 96-well plates and reduced assay volumes of 50-100 microl. A nominal 30 mM source compound concentration provided high microM assay concentrations. Starting at 800 compounds each week, the process reached a steady state of 7200 compounds per week by 1989. Screening in the Applied Biotechnology and Screening Group was centralized with screens operating in lock-step to maximize efficiency. Initial screens were full files run in triplicate. Autoradiography and image analysis were introduced for (125)I receptor ligand screens. Reverse transcriptase (RT) coupled with quantitative PCR and multiplexing addressed several targets in a single assay. By 1992 HTS produced 'hits' as starting matter for approximately 40% of the Discovery portfolio. In 1995, the HTS methodology was expanded to include ADMET targets. ADME targets required each compound to be physically detected leading to the development of automated high throughput LC-MS. In 1996, 90 compounds/week were screened in microsomal, protein binding and serum stability assays. Subsequently, the mutagenic Ames assay was adapted to a 96-well plate liquid assay and novel algorithms permitted automated image analysis of the micronucleus assay. By 1999 ADME HTS was fully integrated into the discovery cycle.
Collapse
Affiliation(s)
- D A Pereira
- Exploratory Medicinal Sciences, Pfizer Global R&D Groton, CT, USA
| | - J A Williams
- Exploratory Medicinal Sciences, Pfizer Global R&D Groton, CT, USA
- Author for correspondence:
| |
Collapse
|
35
|
Planitz BM, Maeder AJ, Williams JA. Synthesising surface matching algorithms using the correspondence framework. Pattern Recognit Image Anal 2007. [DOI: 10.1134/s1054661807020046] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
36
|
Billington RW, Pearson GJ, Williams JA. Uptake of fluoride ions by the glass component of glass ionomer cement. J Dent 2007; 35:452-5. [PMID: 17196321 DOI: 10.1016/j.jdent.2006.11.008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2006] [Revised: 11/13/2006] [Accepted: 11/21/2006] [Indexed: 10/01/2022] Open
Abstract
OBJECTIVES The uptake of F(-) ions by glass ionomer cement (GIC) has been extensively studied but the precise location of the F(-) ion in the GIC structure has not been reported. The aim of this study is to use model materials to elucidate the possible locations. GIC consists of residual particles of aluminosilicate glass surrounded by depleted glass in an ionically crosslinked polymeric matrix. This study evaluates uptake by both unreacted glass particles (RAW) and particles acid-treated to produce a depleted glass surface (DEPLETED). METHOD Three glasses, previously studied as cements, were tested at the particle size used in GICs. LG30 contained Al, Ca, O, P, and Si; LG26 also contained F and AH2 contained Na as well. To produce depleted surfaces they were immersed in acetic acid washed and dried at room temperature. Test samples (N=5) were immersed in KF solution (900ppm F). Control solutions without glass were used. Both were stored at 37C for 48h. F concentrations were measured using ISE with TISAB IV. RESULTS Uptake was Control-test expressed in micromol/g glass. RAW LG30=56 (16); LG26=35(17); AH2=17(31). DEPLETED LG30=285(41); LG26=431(42); AH2=286(50). The levels of F uptake by DEPLETED were comparable to those found with GICs formed with these glasses. CONCLUSIONS The glass particles of GIC, and particularly the depleted zones surrounding them, can account for an appreciable amount of the F uptake observed with cements but do not show the same relation between F content and F uptake previously observed with cements.
Collapse
Affiliation(s)
- R W Billington
- Department of Biomaterials in Relation to Dentistry, Queen Mary University of London, Mile End Road, London E1 4NS, UK.
| | | | | |
Collapse
|
37
|
Abstract
Ion processes are involved in many aspects of glass-ionomer cements. The ions released from the glass take part in the formation of the cement matrix. Although this process has been investigated, particularly using model cement systems, no study provides a complete matrix composition. Combining results from different studies enables an approximate composition to be derived. The importance of Phosphorous in controlling ion release from the glass surface has been identified in a number of studies. The release of ions from the set cement into water (and other aqueous liquids) has been much reported, particularly for fluoride. Over most of the release periods studied (i.e. from >7 days up to 3 years), release of F ion is related to t1/2 indicating a diffusion-controlled process. Other ions, except possibly Na+ also show this relationship. The amount of cumulative F release whilst maintaining this relationship indicates that more F than is in the matrix is involved. Ion chromatography would probably elucidate the precise form of the ionic species released. Glass-ionomer cements take up ions from solutions in which they are immersed. The levels are much higher than required to produce as internal/external equilibrium. Studies using dynamic SIMS and XPS give some information on ion location and elemental association. It is suggested that ToF SIMS would elucidate these further. Re-release of uptaken ions can vary considerably for different cements and ion species. Surface disruption of glass ionomers is caused by both F ion and monofluorophosphate ion and occurs much more readily in F containing cements than in F free ones. The mechanism of this process has not been elucidated. Analysis of the ions released from the cement as disruption occurs should provide an indication of the site of attack.
Collapse
Affiliation(s)
- R W Billington
- Biomaterials in Relation to Dentistry, Institute of Dentistry, Queen Mary University of London, Medical Science Building, Mile End Road, London E1 4NS, UK.
| | | | | |
Collapse
|
38
|
Abstract
One important way in which cutting lubricants operate is by reducing the degree of adhesion between the tool rake-face and the freshly formed chip surface. It is suggested that processes of molecular transport within a network of interfacial capillaries play a dominant role in controlling the effectiveness of cutting fluids, providing that they are capable of reaction with, or adsorption into, the metal surfaces.
Collapse
|
39
|
Williams JA, Pearson GJ, Colles MJ, Wilson M. The Photo-Activated Antibacterial Action of Toluidine Blue O in a Collagen Matrix and in Carious Dentine. Caries Res 2004; 38:530-6. [PMID: 15528907 DOI: 10.1159/000080582] [Citation(s) in RCA: 72] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2003] [Accepted: 01/08/2004] [Indexed: 11/19/2022] Open
Abstract
The main aim of this study was to determine the susceptibility to photo-activated disinfection (PAD) of Streptococcus mutans when the organism was present in a collagen matrix--an environment similar to that which would exist within a carious tooth. In addition, the susceptibility to PAD of bacteria present in carious human teeth was also determined. Light was delivered to the collagen and teeth using a system comprising a 0.8-mm diameter isotropic tip emitting light at 633 +/- 2 nm. A single concentration of TBO (10 microg/ml) was used with both collagen and dentine. Two contact times, 30 and 180 s, were evaluated in intact collagen and additionally, for 180 s only, in collagen partially disrupted by shredding. The effect of energy doses from 1.8 to 14.4 J on the kills attained was assessed by determining the number of surviving viable bacteria. In carious dentine, two contact times, 30 and 60 s and one energy dose, 4.8 J, were used. Antibacterial effects were less than those obtained using planktonic suspensions with a maximum mean log reduction of 1.4 in shredded collagen and dentine. Increasing contact time increased the antibacterial effectiveness in both substrates although this was not always of statistical significance. Shredding the collagen resulted in significantly increased bacterial kills compared to those obtained in intact collagen for the 30-second contact time. The collagen matrix appeared to be a suitable model for carious dentine with advantages of availability and reproducibility. The results of this study have shown that PAD can achieve appreciable kills of oral bacteria, including S. mutans, when the organisms are embedded in a collagen gel or are present in carious teeth.
Collapse
Affiliation(s)
- J A Williams
- Department of Biomaterials in relation to Dentistry, Queen Mary University of London, London, UK.
| | | | | | | |
Collapse
|
40
|
Billington RW, Williams JA, Dorban A, Pearson GJ. Glass ionomer cement: evidence pointing to fluorine release in the form of monofluorophosphate in addition to fluoride ion. Biomaterials 2004; 25:3399-402. [PMID: 15020112 DOI: 10.1016/j.biomaterials.2003.10.028] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2003] [Accepted: 09/25/2003] [Indexed: 10/26/2022]
Abstract
The fluoride ion released from glass ionomer cements into water is reportedly, in part, complexed with other elements present in the cement. When measured using ion selective electrode potentiometry (ISE) a decomplexant TISAB IV (T) is used to convert all fluoride to F- ion which the ISE can detect. In this study, an additional decomplexing procedure (H) designed to hydrolyse fluorine covalently bonded to phosphorus in the monofluorophosphate (MFP) ion into F- was also used. The soluble products from three glass ionomers were analysed by both techniques (H & T). Five 1 x 10 mm discs were each immersed in 10 ml of de-ionised water. This was changed and 4 ml analysed by T and 4 ml by H at 1, 2, 3, 6, 10, 13, 17, 21, 24, 28, and 31 days. H was greater than T for 161 of the 165 pairs ( chi2=74.7, p=<0.001 ). The total cumulative F release H (in micromol/g cement) at 31 days for AH2 was 122.3, s.d. 30.8; LG26 44.0, s.d. 1.55; LG30 10.0, s.d. 3.15 as compared T results of 100.1, s.d. 31.1; 30.3, s.d. 1.92; 3.7, s.d. 1.36, respectively. In all three cases the H was significantly greater than T (matched pair 't' test with p=0.01 or less). H-T was show to have a very strong associative relationship with t1/2 (R2=0.98 or greater p<0.001 ). Evaluating the ratio of P:F in the cements in comparison with the ratio of additional F measured by H to that measured by T produced a relationship log[(H-T)/T]=0.28 x log[P/F]-0.45 with R2=0.999. It is concluded that glass ionomers release more fluorine than is detected by ISE using TISAB IV. If this F is in the form of MFP this may be released more completely into saliva than F as F-, release of which is substantially reduced by Ca2+, since calcium monofluorophosphate is more soluble than CaF2.
Collapse
Affiliation(s)
- R W Billington
- Department of Biomaterials in Relation to Dentistry, Queen Mary University of London, Mile End Road, London E1 4NS, UK.
| | | | | | | |
Collapse
|
41
|
Williams JA, Pearson GJ, Colles MJ, Wilson M. The effect of variable energy input from a novel light source on the photoactivated bactericidal action of toluidine blue O on Streptococcus Mutans. Caries Res 2003; 37:190-3. [PMID: 12740542 DOI: 10.1159/000070443] [Citation(s) in RCA: 74] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2002] [Accepted: 01/22/2003] [Indexed: 11/19/2022] Open
Abstract
Although the combination of toluidine blue O (TBO) dye and laser light at a wavelength of 633 nm has a bactericidal effect, light from laboratory lasers can only be directed externally at a bacterial colony or suspension. In this study a novel delivery system guided the laser light to an 800-micrometer diameter spherical tip (an isotropic tip) from which light radiated producing a uniform sphere of light within the colony or suspension. The system was highly effective in killing TBO-treated Streptococcus mutans NCTC 10449 in stirred planktonic suspension, killing at least 10(9 )cfu/ml. Antibacterial action increased as the delivered energy dose increased. Energy doses of 1.8 J or more produced 100% kills and log reductions of 8-10 cfu/ml. Neither TBO dye nor light alone had a significant antibacterial effect under the experimental conditions used. The existence of a threshold energy, i.e. a minimum energy required before bactericidal action occurred, could not be demonstrated.
Collapse
Affiliation(s)
- J A Williams
- Department of Biomaterials, Eastman Dental Institute for Oral Health Care Sciences, University College London, UK
| | | | | | | |
Collapse
|
42
|
Martin FL, Cole KJ, Muir GH, Kooiman GG, Williams JA, Sherwood RA, Grover PL, Phillips DH. Primary cultures of prostate cells and their ability to activate carcinogens. Prostate Cancer Prostatic Dis 2003; 5:96-104. [PMID: 12496996 DOI: 10.1038/sj.pcan.4500579] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2001] [Revised: 01/22/2002] [Accepted: 02/13/2002] [Indexed: 11/09/2022]
Abstract
Differences in the incidence of prostate cancer (CaP) amongst different migrant populations point to causative agents of dietary and/or environmental origin. Prostate tissues were obtained following transurethral resection of the prostate (TURP) or radical retropubic prostatectomy. After surgery, TURP-derived or tumour-adjacent tissue fragments were minced in warm PFMR-4A medium (37 degrees C) and suspensions pipetted into collagen-coated petri dishes. Non-adherent material was removed by washing with fresh medium after 12 h. Adhered cells subsequently reacted positively with monoclonal antibodies to prostate specific antigen (PSA). PSA was also detected in the medium. The genotoxicities of the chemical carcinogens 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP), its N-hydroxy metabolite (N-OH-PhIP) and benzo[a]pyrene (B[a]P) in adherent cell populations from different donors (n=8) were examined. Cells were treated in suspension for 30 min at 37 degrees C in the presence of the DNA repair inhibitors hydroxyurea (HU) and cytosine arabinoside (ara-C). DNA single-strand breaks were detected in cells by the alkaline single cell-gel electrophoresis ('Comet') assay and quantified by measuring comet tail length (CTL) in microm. All three carcinogens induced dose-related increases in CTLs (P<0.0001) in cells from four donors 24 h post-seeding. However, in cells from a further two donors the genotoxic effects of PhIP, N-OH-PhIP and B[a]P were much less apparent after 48 h than after 24 h in culture. After 96 h in culture, cells from these donors appeared to be resistant to the comet-forming activity of the compounds. However, B[a]P-DNA adducts were still measurable by (32)P-postlabelling for up to 14 days following a 24-h exposure to 50 microM B[a]P in adhered cells from another two donors. This study shows that primary cultures of cells derived from the prostate can activate members of two classes of chemical carcinogens. Further development may provide a robust model system in which to investigate the aetiology of CaP.
Collapse
Affiliation(s)
- F L Martin
- Institute of Cancer Research, Haddow Laboratories, Cotswold Road, Sutton, Surrey, UK.
| | | | | | | | | | | | | | | |
Collapse
|
43
|
Williams JA, Briggs E, Billington RW, Pearson GJ. The effects of adding fluoride compounds to a fluoride-free glass ionomer cement on subsequent fluoride and sodium release. Biomaterials 2003; 24:1301-8. [PMID: 12527272 DOI: 10.1016/s0142-9612(02)00467-2] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Studies have shown that ions in a glass ionomer matrix are 1-10% of the amounts present in the original glass. To measure more precisely the release from a cement matrix, known amounts of ions were added to LG30 glass which was fluoride and sodium-free. Cement without additions acted as the control. 1.4-1.6% of each of sodium, calcium and aluminum fluorides were added to three portions of control blend. The sodium and fluoride release into deionised water from five discs of each cements blend was measured for 8 months. This represented complete release for sodium but not for fluoride. Traces of fluoride and sodium in the glass produced low but measurable amounts indicating about a third of the fluoride and substantially all sodium present in LG30 was released. The addition of calcium fluoride had no significant effect on sodium or fluoride release and aluminium fluoride minimal effects. Adding sodium fluoride significantly enhanced release of both ions although fluoride release was less than from a glass containing 5% fluoride. Only small proportions of the additions, 2-5% of the fluoride and 13% of sodium, were released. Sodium and fluoride appeared to be released independently. For LG30 cements additives were poor at supplying extra ions.
Collapse
Affiliation(s)
- J A Williams
- Department of Biomaterials Research, Eastman Dental Institute, 256 Gray's Inn Road, WC1X 8LD, London, UK
| | | | | | | |
Collapse
|
44
|
Miller MEY, Williams JA. Chronic renal failure in Jamaican children. W INDIAN MED J 2002; 51:220-4. [PMID: 12632636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
In order to document the incidence, aetiology and outcome of chronic renal failure in Jamaican children, paediatric surgeons and hospital based paediatricians island-wide were contacted, and the nephrology records at the island's paediatric nephrology centres searched for data on children < 12-year-old with chronic renal failure diagnosed for the first time between January 1985 and December 2000. Thirty-four children were identified, 21 were male. The cumulative annual incidence of chronic renal failure was 3.2 per million children aged < 12 years. The incidence is likely underestimated, as some children may have been undiagnosed and/or not referred. Glomerulonephritis was the commonest cause of chronic renal failure (50%) followed by obstructive uropathy, reflux nephropathy, renal dysplasia and chronic pyelonephritis (41.2%). Five children (14.7%) had reflux nephropathy (post obstructive in four). Half the children were already in chronic renal failure at time of presentation. Mortality was 65%. In Jamaica, childhood chronic renal failure is due mainly to potentially treatable diseases. Local physicians should be more aware of potentially progressive renal diseases and their prevention. Earlier referral of difficult cases for nephrological consultation is recommended. A paediatric dialysis/transplant programme is needed.
Collapse
Affiliation(s)
- M E Y Miller
- Department of Obstetrics, Gynaecology and Child Health, Section of Child Health, University of the West Indies, Kingston 7, Jamaica, West Indies.
| | | |
Collapse
|
45
|
Abstract
BACKGROUND When compared to radiosurgery, fractionated stereotactic radiotherapy (FSR) for acoustic neuroma (AN) offers escalation of tumor dose (Gy) and potential sparing of auditory and facial nerve functions. METHOD Over the past 6.5 years 287 consecutive patients have received FSR for AN. One hundred fifty patients have follow up greater than 1 year and comprise this report. Non-invasive, repeat-fixation mask allowed simulation via spiral CT. Differential collimation and beam weighting achieved conformality. Three distinct schedules for total dose and fractionation were used. For AN<3.0 cm diameter (mean volume 1.5+/-0.2 cc), > or =3.0 and < or =3.9 cm (mean volume 8.7+/-1.0 cc) and > or =4.0 cm (mean volume 28.3 cc (one case) doses of 5 Gy given in 5 consecutive daily fractions (25 Gy total) (131 patient), 10 fractions of 3 Gy (30 Gy total) (18 pts), or 20 fractions of 2 Gy (1 patient) were given. All treatments were prescribed to the 80% isodose and given via the dedicated 10 MeV accelerator. FINDINGS The percentage decreases in tumor size were 14+/-1 (range: 0-100), 15+/-3 (range 0-38) and 8 for the 25, 30 and 40 Gy regimens, respectively. No patient had growth of AN or developed facial weakness. Two patients developed transient decrease in facial sensation. Rates of hearing preservation were similar for both the larger and smaller tumors. INTERPRETATION Fractionated stereotactic radiotherapy may preserve normal function and control both small and large acoustic neuromas.
Collapse
Affiliation(s)
- J A Williams
- Department of Neurosurgery and Department of Oncology, The Johns Hopkins University School of Medicine, 725 N. Wolfe Street/Hunterian 817, Baltimore, MD 21205, USA
| |
Collapse
|
46
|
Van Der Pol B, Williams JA, Smith NJ, Batteiger BE, Cullen AP, Erdman H, Edens T, Davis K, Salim-Hammad H, Chou VW, Scearce L, Blutman J, Payne WJ. Evaluation of the Digene Hybrid Capture II Assay with the Rapid Capture System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2002; 40:3558-64. [PMID: 12354846 PMCID: PMC130850 DOI: 10.1128/jcm.40.10.3558-3564.2002] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Screening for chlamydial and gonococcal infection has been strongly recommended for all sexually active women under the age of 26. Advances in the ability to detect infection by nucleic acid detection techniques have improved access to screening methods in routine clinical practices. To meet the increasing demand for testing, a high-throughput system is desirable. We evaluated the performance of the Hybrid Capture 2 CT/GC (HC2) assay with the Digene Rapid Capture System (HC2-RCS). The results of HC2-RCS for endocervical samples from 330 women were compared to those of culture and the COBAS Amplicor PCR. For detection of chlamydial infection, HC2-RCS had a sensitivity and a specificity similar to those of PCR (P > 0.5) and an improved sensitivity compared to that of culture (P = 0.007). For identification of gonococcal infections, all assays performed similarly (P > 0.5). The performance of HC2-RCS was also compared to that of the manual HC2 format (HC2-M) with these samples and with 911 endocervical samples collected previously. The performance of HC2-RCS was equivalent to that of HC2-M; the overall concordance rates for the detection of chlamydia and gonorrhea were 99.7% (kappa = 0.97) and 99.8% (kappa = 0.97), respectively. When the HC2 assay was performed with a semiautomated system application designed for high throughput, it demonstrated high sensitivity and a high specificity for detection of both Chlamydia trachomatis and Neisseria gonorrhoeae.
Collapse
Affiliation(s)
- B Van Der Pol
- Department of Medicine, Division of Infectious Diseases, Indiana University School of Medicine, 545 N. Barnhill Drive, Indianapolis, IN 46202-5124, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Rerkasem K, Shearman CP, Williams JA, Morris GE, Phillips MJ, Calder PC, Grimble RF. C-reactive protein is elevated in symptomatic compared with asymptomatic patients with carotid artery disease. Eur J Vasc Endovasc Surg 2002; 23:505-9. [PMID: 12093066 DOI: 10.1053/ejvs.2002.1632] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
OBJECTIVES to investigate the level of inflammatory markers between symptomatic and asymptomatic carotid stenosis patients. DESIGN cross-sectional study. MATERIALS AND METHODS a prospective study of 137 consecutive patients, admitted electively for carotid endarterectomy during 1997-2000, was conducted. 125 patients had cerebrovascular symptoms: either stroke (neurological deficit >24 h), Transient ischaemic attack (neurological deficit<24 h) or amaurosis fugax. Twelve patients were asymptomatic. A medical history and a fasting venous blood sample were taken from each patient around 6 weeks before surgery. The plasma concentrations of cholesterol and of inflammatory markers; (high sensitivity C-reactive protein (hs-CRP), sICAM-1, sVCAM-1, sE-selectin) were determined. RESULTS the concentration of hs-CRP in the symptomatic group (3.9 mg/L) was significantly higher than in the asymptomatic group (2.1 mg/L; p = 0.04). These concentrations were within normal range (<10 mg/L). sICAM-1, sVCAM-1, sE-selectin and total cholesterol concentrations were not different between the two groups. CONCLUSION plasma hs-CRP was elevated in symptomatic compared to asymptomatic patients with carotid artery disease. High sensitivity C-reactive protein has been shown to be of prognostic value in a number of cardiovascular conditions and this study suggests it may be of value to identify patient at high risk of developing neurological deficits.
Collapse
Affiliation(s)
- K Rerkasem
- Department of Vascular Surgery, Southampton General Hospital, UK.
| | | | | | | | | | | | | |
Collapse
|
48
|
Abstract
This study aimed to investigate certain processes of fluoride production which enable glass ionomer cements to leach fluoride. Two fluoroaluminosilicate glasses, G338 and LG26 were used. The free and total fluoride which could be dissolved from the glasses was measured, before and after acetic acid washing. Both glasses contained appreciable amounts of soluble fluoride prior to any acid treatment. The latter process reduced the amount to some 75% of the original levels. Replacing the customary polymeric acid with propionic acid produced a cement which disintegrated in water allowing the amount of fluoride generated by the cement forming process to be measured. Cement production increased soluble fluoride by a further 3%. Both glasses behaved similarly when undergoing the various processes. G338 produced significantly greater quantities of fluoride, of the order of 10, compared with LG26 although containing only three times the amount of fluoride in the glass formula. A substantial proportion, over half, of the total fluoride was complexed especially after contact with cement and when G338 was used. During the period of the experiment, 21 days, total fluoride release did not seem to depend on the square root of time.
Collapse
Affiliation(s)
- J A Williams
- Department of Biomaterials, Eastman Dental Institute for Oral Health Care Sciences, London, UK.
| | | | | |
Collapse
|
49
|
|
50
|
Yuan X, Dillehay LE, Williams JR, Shastri VR, Williams JA. Yuan X, Dillehay LE, Williams JR, Shastri VR, Williams JA. IUdR polymers for combined continuous low-dose rate and high-dose rate sensitization of experimental human malignant gliomas,International Journal of Cancer (Radiation Oncology Investigations) 2001; 96(2) 118-125. Int J Cancer 2002. [DOI: 10.1002/ijc.10220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|